1. ICH Guideline M12 on drug interaction studies 2022. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-ich-guideline-m12-drug-interaction-studies-step-2b_en.pdf (Accessed September 18, 2023).
2. FDA Guidance for Industry: In vitro drug interaction studies - Cytochrom P450 enzyme- and transporter-mediated drug interactions 2020. Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/in-vitro-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions (Accessed September 18, 2023).
3. FDA Guidance for Industry: Clinical drug interaction studies - Cytochrom P450 enzyme- and transporter-mediated drug interactions. 2020. Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions (Accessed September 18, 2023).
4. EMA's Guideline on the Investigation of Drug Interactions 2012. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-drug-interactions_en.pdf (Accessed September 18, 2019).
5. MHLW's Guideline on Drug Interaction for Drug Development and Appropriate Provision of Information (8 Feb 2019). Available online: https://www.mhlw.go.jp/web/t_doc?dataId=00tc3525&dataType=1 (Accessed September 18, 2019).